TrialA Study to Evaluate EDP 938 Regimens in Children With RSV
Trial details
- Registry ID
- NCT04816721
- Phase
- Phase 2
Drug research
EDP-938
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate EDP 938 Regimens in Children With RSVNCT04816721 | ENTA | Phase 2 | Completed | 2024-08-19Actual |
| A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.NCT05568706 | ENTA | Phase 2 | Completed | 2025-06-23Actual |
| Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory TractNCT04633187 | ENTA | Phase 2 | Terminated | 2023-05-31Actual |
| A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult SubjectsNCT04196101 | ENTA | Phase 2 | Completed | 2022-01-04Actual |
A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.
Trial details
- Registry ID
- NCT05568706
- Phase
- Phase 2
Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory Tract
Trial details
- Registry ID
- NCT04633187
- Phase
- Phase 2
A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects
Trial details
- Registry ID
- NCT04196101
- Phase
- Phase 2
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |